Five-year routine cervical cancer screening rates and intervals in a US health plan

Current Medical Research and Opinion

Volumn 24, Issue 9, 2008, Pages 2429-2435

  Schabert, Vernon F ^a   Ye, Xin ^b   Insinga, Ralph P ^c   Singhal, Puneet K ^c   Riedel, Aylin A ^b  

^a Integral Health Decisions Inc   (United States)

^b i3 Innovus   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cervival cancer; Screening intervals; Screening rates

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA BASE; FEMALE; HEALTH CARE PLANNING; HEALTH CARE PRACTICE; HEALTH PROMOTION; HUMAN; INFANT; UNITED STATES; UTERINE CERVIX CANCER; VERRUCA VULGARIS;

ALPHAPAPILLOMAVIRUS; COHORT STUDIES; FEMALE; HUMANS; INSURANCE CARRIERS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 53349144004     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802281671     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66
2. Cervical cancer screening trends, 1992-2000. J Natl Cancer Inst 2003;95:424
3. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40
4. Nelson DE, Bland S, Powell-Griner E, et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 2002;287:2659-67
5. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-44
6. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003;102:765-73
7. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2002. Online: http://apps.nccd.cdc.gov/brfss/Trends/ trendchart.asp?qkey=10070&state=US [Last accessed March 6, 2007]
8. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2004. Online: http://apps.nccd.cdc.gov/brfss/ display.asp?cat=WH&yr=2004&qkey=4426&state=US [Last accessed March 6, 2007]
9. Chu M. Use of the Pap Test as a Cancer Screening Tool, 2001. Medical Expenditure Panel Survey, Statistical Brief #26. Rockville CMD): Agency for Healthcare Research and Quality. Online: http://www.meps.ahrq.gov/ mepsweb/data_files/publications/st26/stat26.pdf [Last accessed March 6, 2007]
10. Rhoades, JA. Access to Care and Use of Preventive Services, 2002: Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64. Medical Expenditure Panel Survey, Statitical Brief #82. Rockville (MD): Agency for Healthcare Research and Quality. Online: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st82/stat82.pdf [Last accessed March 6, 2007]
11. Located at http://progressreport.cancer.gov/ doc_detail.asp?pid=1&did=2005&chid=22&coid=217&mid [Last accessed February 5, 2006]
12. Noller KL, Bettes B, Zinberg S, et al. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259-65
13. Ronco G, Cuzick J, Pierotti P, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomized controlled trial. BMJ 2007;335:28-31
14. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999-3:i-iv, 1-196
15. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
16. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57
17. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342-62
18. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 2003;102:417-27
19. Insinga RP, Glass AG, Rush BB. Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev 2004;13:355-60
20. McPhee SJ, Nguyen TT, Shema SJ, et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002;35:463-73
21. McGovern PG, Lurie N, Margolis KL, et al. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med 1998;14:201-8
22. Paskett ED, Tatum CM, Mack DW, et al. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996;5:721-6
23. Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med 1995;11:94-8
24. Limaye A, Connor AJ, Huang X, et al. Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003 Feb;127:200-4
25. Quest Diagnostics 2003 Annual Report. February 26, 2004. Online: http://media.corporate-ir.net/media_files/NYS/DGX/reports/2003AR/ 03AR_2.pdf [Last accessed March 19, 2007]
26. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000;31:261-70